This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Examples of causes

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

The most frequently used drugs that can be ototoxic are:

  • aminoglycosides - the single most important class of ototoxic drug:
    • streptomycin - mainly vestibulotoxic in adults but in children, cochleotoxicity is prominent
    • neomycin - mainly cochleotoxic
    • gentamicin - mainly vestibulotoxic
  • loop diuretics, particularly, ethacrynic acid and frusemide may cause sensorineural hearing loss. Singly, the effect is usually reversible, but they show synergistic ototoxicity when combined with aminoglycosides, and may cause irreversible damage.

Less commonly used ototoxic drugs include:

  • alcohol, and tobacco - may cause sensorineural deafness
  • aspirin, and quinine and its derivatives - may cause reversible tinnitus and a sensorineural nerve deafness

Rarely:

  • cytotoxic agents - such as cisplatin and nitrogen mustard - sensorineural hearing loss
  • beta-blockers - particularly, practolol - cochleotoxic
  • anticonvulsants - especially, phenytoin and ethosuximide - vestibulotoxic
  • thalidomide used in pregnancy is ototoxic
  • erythromycin - deafness may rarely occur with high doses

Ref: Ototoxicity. Moffat. In: Scott Brown's Otolaryngology. Fifth Edition (1987). Butterworths.


Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.